Abrams SI - Search Results

1

Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.

Stewart TJ, Liewehr DJ, Steinberg SM, Greeneltch KM, Abrams SI. Stewart TJ, et al. Among authors: abrams si. J Immunol. 2009 Jul 1;183(1):117-28. doi: 10.4049/jimmunol.0804132. J Immunol. 2009. PMID: 19542426 Free PMC article.

2

Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21.

Abrams SI, Dobrzanski MJ, Wells DT, Stanziale SF, Zaremba S, Masuelli L, Kantor JA, Schlom J, Masuelle L [corrected to Masuelli L]. Abrams SI, et al. Eur J Immunol. 1995 Sep;25(9):2588-97. doi: 10.1002/eji.1830250928. Eur J Immunol. 1995. PMID: 7589131

3

Adoptive immunotherapy as an in vivo model to explore antitumor mechanisms induced by a recombinant anticancer vaccine.

Abrams SI, Hodge JW, McLaughlin JP, Steinberg SM, Kantor JA, Schlom J. Abrams SI, et al. J Immunother. 1997 Jan;20(1):48-59. doi: 10.1097/00002371-199701000-00005. J Immunother. 1997. PMID: 9101413

4

Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.

Bristol JA, Schlom J, Abrams SI. Bristol JA, et al. Among authors: abrams si. J Immunol. 1998 Mar 1;160(5):2433-41. J Immunol. 1998. PMID: 9498787

5

Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.

Bergmann-Leitner ES, Abrams SI. Bergmann-Leitner ES, et al. Among authors: abrams si. J Immunol. 2000 May 1;164(9):4941-54. doi: 10.4049/jimmunol.164.9.4941. J Immunol. 2000. PMID: 10779805

6

Regression of extensive pulmonary metastases in mice by adoptive transfer of antigen-specific CD8(+) CTL reactive against tumor cells expressing a naturally occurring rejection epitope.

Ryan MH, Bristol JA, McDuffie E, Abrams SI. Ryan MH, et al. Among authors: abrams si. J Immunol. 2001 Oct 15;167(8):4286-92. doi: 10.4049/jimmunol.167.8.4286. J Immunol. 2001. PMID: 11591751

7

Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence.

Liu K, Abrams SI. Liu K, et al. Among authors: abrams si. J Immunol. 2003 Jun 15;170(12):5973-80. doi: 10.4049/jimmunol.170.12.5973. J Immunol. 2003. PMID: 12794124

8

Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma.

Liu K, Abrams SI. Liu K, et al. Among authors: abrams si. J Immunol. 2003 Jun 15;170(12):6329-37. doi: 10.4049/jimmunol.170.12.6329. J Immunol. 2003. PMID: 12794166

9

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy.

Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW. Chakraborty M, et al. Among authors: abrams si. J Immunol. 2003 Jun 15;170(12):6338-47. doi: 10.4049/jimmunol.170.12.6338. J Immunol. 2003. PMID: 12794167

10

The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.

Caldwell SA, Ryan MH, McDuffie E, Abrams SI. Caldwell SA, et al. Among authors: abrams si. J Immunol. 2003 Sep 1;171(5):2402-12. doi: 10.4049/jimmunol.171.5.2402. J Immunol. 2003. PMID: 12928387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters